Latest News

  • Follow the Money: New Solid Cancer Monitoring Platform, Investments in High-Definition PCR

    Diagnostics World News | C2i Genomics closes a series A with a solid cancer monitoring platform out of New York Genome Center and Weill Cornell Medicine. ChromaCode announces another funding round and a high-def PCR test for SARS-CoV-2. Plus more of the latest funding updates from across diagnostics, life sciences, and clinical research.

    Jun 17, 2020
  • The Great Experiment In Taking Trials Virtual

    Diagnostics World News | The necessity of running clinical studies in the midst of a pandemic broke through some of the longstanding fears of sponsors and contract research organizations about the adoption of telehealth technology and the decentralized trial model.

    Jun 16, 2020
  • AMP Surveys Testing Labs, Releases Recommendations For Better Pandemic Response

    Diagnostics World News | The Association for Molecular Pathology surveyed laboratory professionals offering molecular diagnostic tests for clinical diagnosis of SARS-CoV-2 infection. They released the first findings and recommendations based on that survey last week.

    Jun 15, 2020
  • Diagnostics Industry Understanding COVID-19’s Effect On Communities, Other News

    Diagnostics World News | The diagnostics community has continued to expand their understanding of COVID-19, observing the high incidence of cases in certain populations, as well as improving blood tests for the virus.

    Jun 12, 2020
  • Smart Toilets, AI, and Other Efforts to Beat Colorectal Cancer

    Diagnostics World News | In recent months, newly published findings on topics such as family history and the role of the gut microbiome continue to shed light on colorectal cancer, and emerging tools like AI-based screening and a “smart toilet” point toward new possibilities.

    Jun 9, 2020
  • New Tools and Technologies Tackle COVID-19, Other News

    Diagnostics World News | Research news in COVID-19 diagnostics from China’s CDC and the University of Maryland. New tools and technologies are coming from BioDot, Longhorn, and more.

    Jun 5, 2020
  • Challenges And Opportunities In Harnessing The Potential Of Circulating Tumor Cells

    Diagnostics World News Contributed Commentary | Despite the benefits, the potential of circulating tumor cells (CTCs) to serve as a liquid biopsy for cancer has been underutilized, mostly due to the inability to acquire intact CTCs, along with the associated technical challenges. More importantly, until now, the role of CTC information in the design of oncology clinical trials has been greatly overlooked.

    Jun 3, 2020
  • Which Way Forward With Telemedicine? The Regulatory Perspective

    Diagnostics World News | When COVID-19 hit the U.S., a multitude of emergency waivers to the federal statute governing telehealth were necessary to ensure Medicare-age patients could see their doctor and healthcare providers could continue practicing medicine. In the political arena, some saw this as an example of the overly regulated nature of the Centers for Medicare & Medicaid Services. To others, it simply signaled the need to update CMS rules specific to telehealth.

    Jun 2, 2020
  • Diagnostics Play Vital Role In COVID-19 Treatment, Other News

    Diagnostics World News | This week has seen diagnostics continue to play a vital role in combating the COVID-19 pandemic.

    May 29, 2020
  • AI Model Achieves ‘Neurologist-Level’ Diagnostic Performance

    Diagnostics World News | A multidisciplinary team of researchers has developed a machine learning algorithm shown to be “slightly better” than 11 neurologists at diagnosing Alzheimer’s disease in a head-to-head comparison.

    May 28, 2020
  • FNIH, Foundation Medicine, Certara, And More: News From May 2020

    Diagnostics World News | May featured news, products, and partnerships from around the diagnostics community from numerous companies, universities, and organizations, including FNIH, Foundation Medicine, Certara, and more.

    May 27, 2020